Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 10/31/2023 | 96,288,553 | Total gross of voting rights: 96,288,553 |
| Total net* of voting rights: 96,084,083 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$10.32 |
| Daily Change: | 0.84 8.86 |
| Daily Volume: | 25,125 |
| Market Cap: | US$282.360M |
July 22, 2025 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
